R. López

发表

Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.

D. Horn, N. Lago, J. Zorzópulos, 2014, Nucleic acid therapeutics.

Immunostimulatory PyNTTTTGT oligodeoxynucleotides: structural properties and refinement of the active motif.

J. Zorzópulos, J. M. Rodríguez, J. Fló, 2006, Oligonucleotides.

Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.

J. Zorzópulos, D. Riveros, J. Solimano, 2006, Medicina.

OLIGONUCLEOTIDE IMT 504 INDUCES AN IMMUNOGENIC PHENOTYPE AND APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

M. Salón, J. Zorzópulos, D. Riveros, 2006 .

PyNTTTTGT prototype oligonucleotide IMT504 is a potent adjuvant for the recombinant hepatitis B vaccine that enhances the Th1 response.

M. Lahoz, J. Zorzópulos, J. M. Rodríguez, 2005, Vaccine.

IMT504, the Prototype of the Immunostimulatory Oligonucleotides of the PyNTTTTGT Class, Increases the Number of Progenitors of Mesenchymal Stem Cells Both In Vitro and In Vivo: Potential Use in Tissue Repair Therapy

J. Zorzópulos, E. Hofer, N. Chasseing, 2007, Stem cells.

Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route.

R. Frank, J. Zorzópulos, J. M. Rodríguez, 2006, Vaccine.

Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy

S. Opal, D. Horn, M. F. Coronel, 2017, World journal of stem cells.

IMT504: A New and Potent Adjuvant for Rabies Vaccines Permitting Significant Dose Sparing

D. Horn, J. Zorzópulos, O. Larghi, 2012 .

PyNTTTTGT and CpG Immunostimulatory Oligonucleotides: Effect on Granulocyte/Monocyte Colony-Stimulating Factor (GM-CSF) Secretion by Human CD56+ (NK and NKT) Cells

D. Horn, Mariela López, J. Zorzópulos, 2015, PloS one.

Addition of the immunostimulatory oligonucleotide IMT504 to a seasonal flu vaccine increases hemagglutinin antibody titers in young adult and elder rats, and expands the anti-hemagglutinin antibody repertoire.

R. Frank, J. Zorzópulos, V. Savy, 2011, Nucleic acid therapeutics.

Localization of histidine residues relevant for the binding of α-bungarotoxin to the acetylcholine receptor α-subunit in V8-proteolytic fragments

G. Venera, R. López, M. B. D. J. Bonino, 1996, Neurochemistry International.